Thermodynamic and kinetic design principles for amyloid-aggregation inhibitors

Area of Science:

• Biochemistry
• Chemical Kinetics
• Drug Discovery

Background:

• Amyloid-fibril formation is central to protein-misfolding diseases.
• Developing effective inhibitors is hindered by complex aggregation mechanisms and timescales.
• Identifying optimal binding targets on aggregating proteins remains a challenge.

Purpose of the Study:

• To develop a comprehensive kinetic theory for amyloid-aggregation inhibition.
• To identify fundamental thermodynamic and kinetic signatures of effective inhibitors.
• To provide physical laws for guiding the design of novel therapeutics.

Main Methods:

• Development of a quantitative kinetic theory.
• Analysis of rate constants for aggregation and inhibitor binding.
• Identification of relationships between inhibitor binding and aggregation kinetics.

Main Results:

• The study reveals key thermodynamic and kinetic signatures of effective amyloid-aggregation inhibitors.
• Quantitative relationships between aggregation and binding rate constants were established.
• The significant role of inhibitor 'on-rates' in binding was highlighted.

Conclusions:

• The presented kinetic theory offers a framework for understanding and designing amyloid-aggregation inhibitors.
• Optimizing inhibitor on-rates is a critical factor for potent therapeutic development.
• This work provides general physical laws to guide future research in protein-misfolding disease therapeutics.